CHICAGO--(BUSINESS WIRE)-- Kiadis Pharma, a biopharmaceutical company based in The Netherlands, announced that it has entered into a licensing agreement with Hospira, Inc. (NYSE: HSP), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results